Drug recall · August 20, 2025
Amlodipine and Olmesartan Medoxomil Tablets recall
Why: Failed Dissolution Specifications: low dissolution results
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30
- Lots / codes
Lot 23121560, Exp 4/30/2026
- Quantity
- 8,568 bottles
- Company
- Ascend Laboratories, LLC, Bedminster, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 21, 2025 · Voluntary: Firm initiated
- Classified
- August 8, 2025
- Reported
- August 20, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / olmesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.